The Capsule Endoscopy Market is experiencing significant growth owing to the increasing adoption of minimally invasive diagnostic technologies by healthcare providers for the detection of gastrointestinal diseases. Capsule endoscopy has revolutionised the diagnosis of conditions such as Crohn’s disease, obscure gastrointestinal bleeding, small bowel tumours and colorectal disorders by offering a non-invasive alternative to conventional endoscopic procedures. Improvements in wireless communication technologies, high-resolution imaging systems, AI-assisted image analysis, and improved data recording capabilities are enhancing diagnostic accuracy while providing increased patient comfort and convenience. Capsule endoscopy of the small bowel continues to be the most widely used, but colon and oesophageal capsules are becoming more popular in sophisticated healthcare settings.
The global Capsule Endoscopy Market is expected to grow from USD 506.61 Million in 2025 to USD 972.00 Million by 2033, at a CAGR of 8.51% during the forecast period of 2026–2033. The growth of the market is driven by the increasing prevalence of gastrointestinal disorders, growing demand for minimally invasive diagnostic procedures, increasing investments in hospital and ambulatory care infrastructure, and continuous technological innovations in capsule imaging systems. Furthermore, the integration of artificial intelligence, longer battery life, cloud-based data management, and increasing healthcare accessibility in emerging economies will likely lead to substantial growth prospects during the forecast period.
Capsule Endoscopy Market
Key Players:
Some of the major companies operating in the Capsule Endoscopy Market are Boston Scientific Corporation, Medtronic, Olympus Corporation, Fujifilm Holdings Corporation, Cook Medical, CapsoVision, CapsoCam Plus, Check-Cap, ConMed Corporation, INTROMEDIC, RF Co., Ltd., Karl Storz SE & Co. KG, and others.
Strategic Developments & Industry Innovations:
-
In January 2024, Boston Scientific announced a definitive agreement to acquire Axonics, strengthening its position in medical technologies focused on gastrointestinal and urinary tract disorders.
-
In January 2025, CapsoVision received FDA clearance for CapsoCam Plus® for pediatric patients aged two years and older, expanding access to non-invasive gastrointestinal endoscopic devices for children.
-
In May 2024, Cook Medical entered a strategic distribution agreement with EnteraSense to commercialize the PillSense™ GI Bleed Detection System across the United States, improving access to innovative gastrointestinal diagnostic solutions.
Top Players Driving Innovation in the Capsule Endoscopy Market:
1. Boston Scientific Corporation: Advancing Next-Generation Gastrointestinal Diagnostics
Boston Scientific is a leader in innovation in capsule endoscopy, providing advanced gastrointestinal diagnostic solutions for accurate and non-invasive disease detection. It has expanded into global healthcare markets, with expertise in imaging technologies, digital health solutions and minimally invasive procedures.
Boston Scientific is dedicated to investing in R&D, making strategic acquisitions, and collaborating with healthcare providers to grow its diagnostic capabilities and improve patient outcomes in gastrointestinal care. The company’s strong global distribution network and focus on innovation are key growth drivers in the market.
2. CapsoVision: Transforming Capsule Endoscopy Through Advanced Imaging Technology
CapsoVision is a leader in capsule endoscopy with its innovative CapsoCam platform. The whole gastrointestinal tract is viewed panoramically with several cameras. The technology enhances image quality, diagnostic confidence and procedural efficiency.
CapsoVision’s recent expansion into paediatric applications underscores the company’s commitment to expanding access to minimally invasive diagnostics. The company is well placed to capitalise on the fast growing capsule endoscopy market due to its ongoing technology development and strategic partnerships in the healthcare space.
3. Cook Medical: Expanding Access to Innovative Gastrointestinal Diagnostic Solutions
Cook Medical is a leader in innovative medical technology and in gastrointestinal diagnostics. The company’s mission is to advance patient portal through minimally invasive procedures, advanced imaging technologies and streamlined diagnostic processes.
Cook Medical’s strategic partnership with EnteraSense is a testament to its commitment to expanding access to novel gastrointestinal diagnostic tools. The company is dedicated to developing capsule endoscopy technologies throughout the world, and continues to invest in product development, physician education and healthcare partnerships.
How the Capsule Endoscopy Market Is Transforming Gastrointestinal Disease Diagnosis?
The Capsule Endoscopy Market is expected to grow steadily owing to the increasing emphasis of healthcare systems on non-invasive diagnostic market that are easily tolerated by patients. The growing incidence of Crohn’s disease, gastrointestinal bleeding, colorectal cancer, and other digestive disorders is fueling the demand for advanced capsule-based imaging technologies that can enable accurate and timely diagnosis.
Leading companies such as Boston Scientific, CapsoVision, and Cook Medical are accelerating innovation with the integration of artificial intelligence, high-resolution imaging systems, enhanced data analytics, and next-generation capsule technologies. Healthcare providers are looking for safer, more efficient ways to diagnose and therefore capsule endoscopy is expected to play an increasingly important role in the management of gastrointestinal disease, improving patient outcomes and expanding access to advanced diagnostic care across global healthcare markets.
